Back to comparisons

Comparison

NMN vs Inositol (Myo-Inositol)

FieldNMNInositol (Myo-Inositol)
Categoryneuroprotectiveneuroprotective
Dose range250–1000mg2000–18000mg
Half-life
Onset
EvidenceEVIDENCEBEVIDENCEA
Safety●●●●●●●●●●
Legal (US)USOTCUSOTC
PubMed refs6003800

The comparison in plain English

Auto-generated from data

NMN and Inositol (Myo-Inositol) are both in the neuroprotective category respectively. NMN Nicotinamide mononucleotide — NAD+ precursor. Inositol (Myo-Inositol) Sugar alcohol that functions as a second messenger in cellular signaling.

Bottom line

NMN (evidence B, safety 5/5) has a stronger evidence base than Inositol (Myo-Inositol) (evidence A, safety 5/5). NMN has the slightly cleaner safety profile. For users new to either, the higher-evidence option is the safer first try.

Choose NMN if

NMN is the better fit when your goal aligns with its mechanism (Direct precursor to NAD+ — one biosynthetic step closer than nicotinamide riboside, bypassing the NRK1/NRK2 enzymatic step) and the dose range (250–1000mg) suits your protocol. Half-life is —h.

Choose Inositol (Myo-Inositol) if

Inositol (Myo-Inositol) is the better fit when your goal aligns with its mechanism (Functions as a precursor to phosphatidylinositol, a key second messenger system in intracellular signaling) and the dose range (2000–18000mg) suits your protocol. Half-life is —h.

Build a stack with bothOpen builder →
Check interactionsOpen checker →